$GTCH GBT Technologies Inc. 's (OTC Pink: GTCH) AI-powered qTerm human vital signs device is adding a blood pressure measurement feature, according to a recent press release. In an interview with Investorideas.com, GBT's CTO, Danny Rittman explained that this feature was intended to be included in the first version of the qTerm device but was delayed in an effort to get the device to market sooner to help with the COVID-19 pandemic.
"Originally the qTerm device was planned to be with four features but we wanted to accelerate and have an initial release to the market as soon as possible," Rittman said. "We came to the conclusion that blood oxygen, heart rate and body temperature were definitely going to be major factors to assist in the early signs detection [of the virus]."
Rittman said the blood pressure feature "will be done using advanced technology and sensing systems," and outlined the tech involved in the aforementioned press release:
Using a digital embedded sensor electronic system, and machine-learning algorithms we develop an embedded optical based analysis system to measure blood pressure. This miniature system will be based on photoplethysmography (PPG) method and installed within our qTerm medical device.
"The device itself may get a bit larger but not much, maybe a bit longer or thicker," he said. "We've tried to keep it the same size."